Acadian Asset Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Acadian Asset Management’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-58,599	Closed	-$1.11M	–	2210
2019 Q1	$1.11M	Buy	+58,599	New	+$951K	﹤0.01%	852
2015 Q3	–	Sell	-27,900	Closed	-$543K	–	1589
2015 Q2	$543K	Buy	27,900 +27,178	+3,764%	+$481K	﹤0.01%	779
2015 Q1	$13K	Buy	+722	New	+$12.1K	﹤0.01%	1171

Other funds holding OSIR

FGAM

Financial Gravity Asset Management Lakeway, Texas $562M AUM

Acadian Asset Management's OSIR Position: Q2 2019 in Review

Acadian Asset Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 58,599 shares — an estimated $1.11M sold.

Acadian Asset Management first reported a position in OSIR in Q1 2015 and held it in 3 quarters. The position peaked at $1.11M in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

Acadian Asset Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Acadian Asset Management sold 58,599 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $1.11M.
Acadian Asset Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2015 and held it in 3 quarters.
Acadian Asset Management's Osiris Therapeutics, Inc. Common Stock position peaked at $1.11M in Q1 2019.
1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Acadian Asset Management's 13F filing for Q2 2019, filed 8 Aug 2019.